UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

November 712, 2025

Claritev Corporation

(Exact name of registrant as specified in its charter)

Delaware

001-39228

84-3536151

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

7900 Tysons One Place, Suite 400

McLean, Virginia 22102

(212) 780-2000

(Address, including zip code, and telephone number,

including area code, of registrant’s principal executive offices)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

~~TradingSymbol(s)~~

~~Name of each exchange on which registered~~

Shares of Class A Common Stock, $0.0001 par value per share

CTEV

New York Stock Exchange

~~CTEV~~

~~New York Stock Exchange~~

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐ ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ ¨

~~Unless~~Item ~~the~~8.01 ~~context~~Other ~~otherwise requires, "we," "us," "our," "Claritev" and the "Company" refer to Claritev Corporation, a Delaware corporation, and its consolidated subsidiaries.~~Events

~~Item~~On 2November 12, 2025, Claritev Corporation (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with certain affiliates of Hellman & Friedman (collectively, the “Selling Stockholders”) and Barclays Capital Inc.~~02 Results~~, Guggenheim Securities, LLC and Wells Fargo Securities, LLC, as representatives of ~~Operations~~the several underwriters named in Schedule I thereto (collectively, the “Underwriters”), relating to the offer and ~~Financial~~sale by ~~Condition~~the Selling Stockholders of 1,500,000 shares of Class A common stock, par value $0.0001 per share, of the Company (the “Class A Common Stock”), at a price to the public of $51.50 per share (the “Offering”). In addition, the Selling Stockholders granted the Underwriters a 30-day option to purchase up to an additional 225,000 shares of Class A Common Stock. The Company did not sell any shares of Class A Common Stock in the Offering and did not receive any proceeds from the sale of the Class A Common Stock by the Selling Stockholders. The Offering closed on November 14, 2025.

OnThe ~~November 7~~Underwriting Agreement contains customary representations and warranties, agreements ~~2025~~and obligations, ~~the~~closing conditions and termination provisions. The Company ~~issued~~and athe ~~press~~Selling ~~release~~Stockholders ~~announcing~~have ~~its~~agreed ~~financial~~to ~~results~~indemnify the ~~for~~Underwriters against certain liabilities and to contribute to payments the ~~third~~Underwriters ~~quarter~~may ~~ended~~be ~~September~~required ~~30,~~to ~~2025.~~make in the event of any such liabilities.

AThe ~~copy~~foregoing description of the ~~press~~Underwriting ~~release~~Agreement does not purport to be complete and is ~~included~~subject asto ~~Exhibit~~and ~~99.1~~is qualified in its entirety by reference to ~~this~~the ~~Current~~Underwriting ~~Report~~Agreement, ona ~~Form~~copy ~~8-K~~of ~~and~~which is attached hereto as Exhibit 1.1 and the terms of which are incorporated herein by reference.

~~The information in this~~ Item 29.~~02,~~01 ~~including~~Financial ~~99.1,~~Statements ~~is furnished~~ and shall not be deemed "filed" for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to liabilities under that section, nor shall it be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filingsExhibits.

~~Item~~(d) ~~9.01 Financial Statements and~~ Exhibits.

(d) Exhibits.

Exhibit No.	Description
1.1	Underwriting Agreement, dated as of November 12, 2025, among Claritev Corporation, the Selling Stockholders and Barclays Capital Inc., Guggenheim Securities, LLC and Wells Fargo Securities, LLC.
104	The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

~~The~~SIGNATURES ~~following exhibits are included in this Form 8-K:~~

Exhibit No.						Description of Exhibit
99.1						Press Release, dated November 7, 2025, reporting the Company's financial results for the third quarter ended September 30, 2025.
104						Cover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document).

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

~~SIGNATURES~~Dated: November 14, 2025

~~Pursuant~~Claritev toCorporation ~~the~~By: ~~requirements~~/s/ ofDouglas ~~the~~M. ~~Securities~~Garis ~~Exchange~~Name: ~~Act~~Douglas ofM. ~~1934,~~Garis ~~the~~Title: ~~registrant~~Executive ~~has~~Vice ~~duly~~President ~~caused~~and ~~this~~Chief ~~report~~Financial ~~to be signed on its behalf by the undersigned hereunto duly authorized.~~Officer

Dated: November 7, 2025

Claritev Corporation

By: /s/ Douglas M. Garis

Name: Douglas M. Garis

Title: Executive Vice President and Chief Financial Officer

Filing Compare · Claritev Corp